Hasti Robbie1, Athol U Wells2,3,4, Cheng Fang5, Joseph Jacob6,7, Simon L F Walsh8, Arjun Nair9, Rose Camoras2, Sujal R Desai2, Anand Devaraj2,3,4. 1. King's College Hospital NHS Foundation Trust, Denmark Hill, Brixton, SE5 9RS, London , UK. hasti.robbie@nhs.net. 2. Royal Brompton and Harefield NHS Foundation Trust, Sydney St, Chelsea, SW3 6NP, London, UK. 3. National Heart and Lung Institute (NHLI), Dovehouse St, Chelsea, SW3 6LY, London, UK. 4. Imperial College London, Exhibition Rd, South Kensington, London, SW7 2BU, UK. 5. King's College Hospital NHS Foundation Trust, Denmark Hill, Brixton, SE5 9RS, London , UK. 6. Centre for Medical Image Computing, 90 High Holborn, London, UK. 7. UCL Respiratory, Rayne building, 5 University Street, London, UK. 8. National Heart and Lung Institute, Imperial College, London, UK. 9. University College London Hospital, 235 Euston Rd, Fitzrovia, NW1 2BU, London, UK.
Abstract
OBJECTIVES: In patients with IPF, this study aimed (i) to examine the relationship between serial change in CT parameters of lung volume and lung function, (ii) to identify the prognostic value of serial change in CT parameters of lung volume, and (iii) to define a threshold for serial change in CT markers of lung volume that optimally captures disease progression. METHODS: Serial CTs were analysed for progressive volume loss or fibrosis progression in 81 IPF patients (66 males, median age = 67 years) with concurrent forced vital capacity (FVC) (median follow-up 12 months, range 6-23 months). Serial CT measurements of volume loss comprised oblique fissure posterior retraction distance (OFPRD), aortosternal distance (ASD), lung height corrected for body habitus (LH), and automated CT-derived total lung volumes (ALV) (measured using commercially available software). Fibrosis progression was scored visually. Serial changes in CT markers and FVC were compared using regression analysis, and evaluated against mortality using Cox proportional hazards. RESULTS: There were 58 deaths (72%, median survival = 17 months). Annual % change in ALV was most significantly related to annual % change in FVC (R2 = 0.26, p < 0.0001). On multivariate analysis, annual % change in ASD predicted mortality (HR = 0.97, p < 0.001), whereas change in FVC did not. A 25% decline in annual % change in ASD best predicted mortality, superior to 10% decline in FVC and fibrosis progression. CONCLUSION: In IPF, serial decline in CT markers of lung volume and, specifically, annualised 25% reduction in aortosternal distance provides evidence of disease progression, not always identified by FVC trends or changes in fibrosis extent. KEY POINTS: • Serial decline in automated and surrogate markers of lung volume on CT corresponds to changes in FVC. • Annualised reductions in the distance between ascending aorta and posterior border of the sternum on CT predict mortality beyond annualised percentage change in FVC.
OBJECTIVES: In patients with IPF, this study aimed (i) to examine the relationship between serial change in CT parameters of lung volume and lung function, (ii) to identify the prognostic value of serial change in CT parameters of lung volume, and (iii) to define a threshold for serial change in CT markers of lung volume that optimally captures disease progression. METHODS: Serial CTs were analysed for progressive volume loss or fibrosis progression in 81 IPF patients (66 males, median age = 67 years) with concurrent forced vital capacity (FVC) (median follow-up 12 months, range 6-23 months). Serial CT measurements of volume loss comprised oblique fissure posterior retraction distance (OFPRD), aortosternal distance (ASD), lung height corrected for body habitus (LH), and automated CT-derived total lung volumes (ALV) (measured using commercially available software). Fibrosis progression was scored visually. Serial changes in CT markers and FVC were compared using regression analysis, and evaluated against mortality using Cox proportional hazards. RESULTS: There were 58 deaths (72%, median survival = 17 months). Annual % change in ALV was most significantly related to annual % change in FVC (R2 = 0.26, p < 0.0001). On multivariate analysis, annual % change in ASD predicted mortality (HR = 0.97, p < 0.001), whereas change in FVC did not. A 25% decline in annual % change in ASD best predicted mortality, superior to 10% decline in FVC and fibrosis progression. CONCLUSION: In IPF, serial decline in CT markers of lung volume and, specifically, annualised 25% reduction in aortosternal distance provides evidence of disease progression, not always identified by FVC trends or changes in fibrosis extent. KEY POINTS: • Serial decline in automated and surrogate markers of lung volume on CT corresponds to changes in FVC. • Annualised reductions in the distance between ascending aorta and posterior border of the sternum on CT predict mortality beyond annualised percentage change in FVC.
Authors: R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: H G Kim; D P Tashkin; P J Clements; G Li; M S Brown; R Elashoff; D W Gjertson; F Abtin; D A Lynch; D C Strollo; J G Goldin Journal: Clin Exp Rheumatol Date: 2010-11-03 Impact factor: 4.473
Authors: Margaret L Salisbury; David A Lynch; Edwin J R van Beek; Ella A Kazerooni; Junfeng Guo; Meng Xia; Susan Murray; Kevin J Anstrom; Eric Yow; Fernando J Martinez; Eric A Hoffman; Kevin R Flaherty Journal: Am J Respir Crit Care Med Date: 2017-04-01 Impact factor: 21.405
Authors: Fabien Maldonado; Teng Moua; Srinivasan Rajagopalan; Ronald A Karwoski; Sushravya Raghunath; Paul A Decker; Thomas E Hartman; Brian J Bartholmai; Richard A Robb; Jay H Ryu Journal: Eur Respir J Date: 2013-04-05 Impact factor: 16.671
Authors: Stephen M Humphries; Kunihiro Yagihashi; Jason Huckleberry; Byung-Hak Rho; Joyce D Schroeder; Matthew Strand; Marvin I Schwarz; Kevin R Flaherty; Ella A Kazerooni; Edwin J R van Beek; David A Lynch Journal: Radiology Date: 2017-05-10 Impact factor: 11.105